These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 598952)

  • 41. Graphical approach for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes.
    Macheras PE
    J Pharm Sci; 1985 May; 74(5):582-4. PubMed ID: 4020640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Derivation and presentation of formulas for drug concentrations in two-, three- and four-compartment pharmacokinetic models.
    Świętaszczyk C; Jødal L
    J Pharmacol Toxicol Methods; 2019; 100():106621. PubMed ID: 31351949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum creatinine and drug half-lives.
    Kampmann J; Hansen JM; Siersbaek-Nielsen K; Kristensen M
    JAMA; 1973 Jan; 223(2):193. PubMed ID: 4739466
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical pharmacology. Elimination of drugs.
    Barber HE; Petrie JC
    Br Med J (Clin Res Ed); 1981 Mar; 282(6266):809-10. PubMed ID: 6783180
    [No Abstract]   [Full Text] [Related]  

  • 45. Quick estimation of kinetic parameters for a compartment with exponential absorption rate and first-order elimination rate.
    Thron CD
    J Pharm Sci; 1977 Jan; 66(1):127-9. PubMed ID: 833728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A survey of pharmacokinetic data from pregnant women.
    Cummings AJ
    Clin Pharmacokinet; 1983; 8(4):344-54. PubMed ID: 6617042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of the contributions of permeability and flow of intercompartmental clearance.
    Stec GP; Atkinson AJ
    J Pharmacokinet Biopharm; 1981 Apr; 9(2):167-80. PubMed ID: 7277207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A simple method for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes.
    Bialer M
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):111-3. PubMed ID: 7381690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rationale for apparent differences in pharmacokinetic aspects of model compounds determined from blood level data and urinary excretion data in rats.
    Amin YM; Nagwekar JB
    J Pharm Sci; 1976 Sep; 65(9):1341-5. PubMed ID: 966150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic criteria for the evaluation of retard formulations.
    Meier J; Nüesch E; Schmidt R
    Eur J Clin Pharmacol; 1974 Oct; 7(6):429-32. PubMed ID: 4155170
    [No Abstract]   [Full Text] [Related]  

  • 51. Some pitfalls in selecting descriptive pharmacokinetic models.
    Vree TB; Hekster YA; Oosterbaan MJ; Termond EF
    Drug Intell Clin Pharm; 1984 Sep; 18(9):708-13. PubMed ID: 6479019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Composite pharmacokinetic profiling.
    Colburn WA; Gibson DM
    J Pharm Sci; 1984 Nov; 73(11):1667-9. PubMed ID: 6097666
    [No Abstract]   [Full Text] [Related]  

  • 53. Should clearance be normalised to body surface or to lean body mass?
    Hallynck TH; Soep HH; Thomis JA; Boelaert J; Daneels R; Dettli L
    Br J Clin Pharmacol; 1981 May; 11(5):523-6. PubMed ID: 7272167
    [No Abstract]   [Full Text] [Related]  

  • 54. An alternative method for calculating simple pharmacokinetic parameters for zero-order absorption and first-order elimination processes.
    Bialer M
    Biopharm Drug Dispos; 1981; 2(4):323-7. PubMed ID: 7317571
    [No Abstract]   [Full Text] [Related]  

  • 55. Physiologic pharmacokinetic models and interanimal species scaling.
    Rowland M
    Pharmacol Ther; 1985; 29(1):49-68. PubMed ID: 3914645
    [No Abstract]   [Full Text] [Related]  

  • 56. Hydrodynamic analog model for pharmacokinetics I: model and its usefulness.
    Vaidhyanathan VS
    J Pharm Sci; 1975 Jan; 64(1):88-92. PubMed ID: 1133713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Choice of parameters in pharmacokinetic analysis [proceedings].
    House FR
    Br J Clin Pharmacol; 1979 Apr; 7(4):432P-433P. PubMed ID: 444382
    [No Abstract]   [Full Text] [Related]  

  • 58. Estimation of variance for harmonic mean half-lives.
    Lam FC; Hung CT; Perrier DG
    J Pharm Sci; 1985 Feb; 74(2):229-31. PubMed ID: 3989700
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter: Drug elimination and renal function.
    Kristensen M; Molholm HJ; Kampmann J; Lumholtz B; Siersbaek-Nielsen K
    J Clin Pharmacol; 1974; 14(5-6):307-8. PubMed ID: 4829522
    [No Abstract]   [Full Text] [Related]  

  • 60. Distribution volume related to body weight and protein binding.
    Jusko WJ; Chiang ST
    J Pharm Sci; 1982 Apr; 71(4):469-70. PubMed ID: 7086663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.